MedPath

OMNIPAQUE 300 LIQ IV SAR 647MG/ML

OMNIPAQUE 300 LIQ IV SAR 647MG/ML

Discontinued
DIN Number

02018128

Drug Class

Human

Market Date

Dec 31, 1985

Company
HC

sanofi canada, inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02018128
AIG Number0103970029
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08AB02 IOHEXOL
Product Specifications
Dosage FormLiquid
Route of AdministrationSubarachnoidal ,  Intravenous
AHFS Classification36:68.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IODINE (IOHEXOL)Active
Strength: 300 MG / ML
Monograph: IODINE (IOHEXOL)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.